Clozapine prescribing barriers in the management of treatment-resistant schizophrenia
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000027694
Abstract: Abstract Background: Treatment-resistant schizophrenia is prevalent and difficult to manage, as patients fail multiple antipsychotic trials before being considered as treatment-resistant. Currently clozapine is the only Food and Drug Administration-approved pharmacotherapy for treatment-resistant schizophrenia but… read more here.
Keywords: prescriber; clozapine; treatment; resistant schizophrenia ... See more keywords
Do you think medicines can be prescribed in a more eco-directed, greener way? A qualitative study based on public and prescriber focus groups on the impact of pharmaceuticals in Scotland’s water environment
Sign Up to like & getrecommendations! Published in 2025 at "BMJ Open"
DOI: 10.1136/bmjopen-2024-088066
Abstract: Objectives This qualitative study explored public and prescriber awareness of pharmaceutical pollution in the water environment and eco-directed sustainable prescribing (EDSP) as a mitigation strategy to reduce the environmental impact of prescribing in Scotland. Design… read more here.
Keywords: environment; focus; focus groups; qualitative study ... See more keywords
Evaluation of prescriber responses to pharmacogenomics clinical decision support for thiopurine S‐methyltransferase testing
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Health-System Pharmacy"
DOI: 10.2146/ajhp170280
Abstract: Purpose Results of a study of prescribers’ responses to a pharmacogenomics‐based clinical decision support (CDS) alert designed to prompt thiopurine S‐methyltransferase (TPMT) status testing are reported. Methods A single‐center, retrospective, chart review–based study was conducted… read more here.
Keywords: responses pharmacogenomics; prescriber; decision support; thiopurine ... See more keywords